RACHAEL PARKER: Open Payments
NPI 1356788129 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 20 payments from 10 companies in 2025. Trend: 2023 $55 · 2024 $362 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $146 |
| Novo Nordisk Inc | 3 | $60 |
| ABBVIE INC. | 2 | $40 |
| PFIZER INC. | 2 | $39 |
| Lilly USA, LLC | 2 | $36 |
| Exact Sciences Corporation | 1 | $27 |
| Abbott Laboratories | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Radius Health, Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: FARXIGA, Rybelsus, MOUNJARO, Cologuard Collection Kit, FREESTYLE LIBRE 3, PREVNAR 20, QULIPTA, UBRELVY.
Industry payments across IA — which companies pay providers there.
